Author Tzvetkov, Mladen Vassilev
-
2021 | Journal Article | Research Paper |
Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
Steimer, W.; Pischa, K.; Leucht, S.; Kullmann, M.; Ouethy, T.; Rafehi, M. & Matthaei, J. et al. (2021)
Frontiers in Pharmacology, 12. DOI: https://doi.org/10.3389/fphar.2021.688950
Details DOI
-
2017 | Journal Article
Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families (vol 398, pg 237, 2017)
Chen, J.; Brockmoeller, J.; Seitz, T.; Koenig, J.; Tzvetkov, M. V. & Chen, X. (2017)
Biological Chemistry, 398(7). DOI: https://doi.org/10.1515/hsz-2017-0129
Details DOI PMID PMC WoS
-
2017 | Journal Article
Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families
Chen, J.; Brockmoeller, J.; Seitz, T.; Koenig, J.; Tzvetkov, M. V. & Chen, X. (2017)
Biological Chemistry, 398(2) pp. 237-249. DOI: https://doi.org/10.1515/hsz-2016-0236
Details DOI PMID PMC WoS
-
2016 | Journal Article
Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption
Stamer, U. M.; Frank, M.; Stüber, F.; Brockmöller, J. ; Steffens, M. & Tzvetkov, M. V. (2016)
Pain, 157(11) pp. 2467-2475. DOI: https://doi.org/10.1097/j.pain.0000000000000662
Details DOI PMID PMC WoS
-
2016 | Journal Article
OCT1 Mediates Hepatic Uptake of Sumatriptan and Loss-of-Function OCT1 Polymorphisms Affect Sumatriptan Pharmacokinetics
Matthaei, J.; Kuron, D.; Faltraco, F.; Knoch, T.; Pereira, J. N. D. S.; Abu Abed, M. & Prukop, T. et al. (2016)
Clinical Pharmacology & Therapeutics, 99(6) pp. 633-641. DOI: https://doi.org/10.1002/cpt.317
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
Matthaei, J.; Tzvetkov, M. V.; Gal, V.; Sachse-Seeboth, C.; Sehrt, D.; Hjelmborg, J. B. & Hofmann, U. et al. (2016)
Genome Medicine, 8 art. 119. DOI: https://doi.org/10.1186/s13073-016-0372-2
Details DOI PMID PMC WoS
-
2015 | Conference Abstract
OCT1 is the clinically relevant hepatic transporter of sumatriptan: in vitro and in vivo evidences
Kuron, D.; Matthaei, J.; Brockmoeller, J. & Tzvetkov, M. V. (2015)
Naunyn-Schmiedeberg s Archives of Pharmacology, 388 81st Annual Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und Toxikologie-e-V, Kiel, GERMANY.
New york: Springer.
Details WoS
-
2015 | Conference Abstract
Functional characterization of the genetic polymorphisms in the OCT1 promoter
Bokelmann, K.; Brockmoeller, J. & Tzvetkov, M. V. (2015)
Naunyn-Schmiedeberg s Archives of Pharmacology, 388 , Kiel, GERMANY.
New york: Springer.
Details WoS
-
2015 | Conference Abstract
Alkaloids as substrates and inhibitors of organic cation transporters
Chen, J.; Brockmoeller, J.; Chen, X. & Tzvetkov, M. V. (2015)
Naunyn-Schmiedeberg s Archives of Pharmacology, 388 81st Annual Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und Toxikologie-e-V, Kiel, GERMANY.
New york: Springer.
Details WoS
-
2015 | Conference Abstract
Does the apparently predictive haplotype Met408-Del420 really exist and how strong it affects OCT1 activity?
Seitz, T.; Bokelmann, K.; Pereira, J. N. dos S.; Mueller, T.; Brockmoeller, J.; Koepsell, H. & Tzvetkov, M. V. (2015)
Naunyn-Schmiedeberg s Archives of Pharmacology, 388 81st Annual Meeting of the Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und Toxikologie-e-V, Kiel, GERMANY.
New york: Springer.
Details WoS
-
2015 | Journal Article
Impact of mineralocorticoid receptor polymorphisms on urinary electrolyte excretion with and without diuretic drugs
Dalila, N.; Brockmoeller, J.; Tzvetkov, M. V.; Schirmer, M.; Haubrock, M. & Vormfelde, S. V. (2015)
Pharmacogenomics, 16(2) pp. 115-127. DOI: https://doi.org/10.2217/pgs.14.163
Details DOI PMID PMC WoS
-
2015 | Journal Article
High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors
Hasheminasab, S.-M.; Tzvetkov, M. V.; Schumann, C.; Ruediger, S.; Boeck, S.; Heinemann, V. & Kaechele, V. et al. (2015)
Pharmacogenomics, 16(14) pp. 1605-1619. DOI: https://doi.org/10.2217/pgs.15.97
Details DOI PMID PMC WoS
-
2015 | Journal Article |
Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1
Seitz, T.; Stalmann, R.; Dalila, N.; Chen, J. ; Pojar, S.; Pereira, J. N. dos S. & Kraetzner, R. et al. (2015)
Genome Medicine, 7 art. 56. DOI: https://doi.org/10.1186/s13073-015-0172-0
Details DOI PMID PMC WoS
-
2014 | Journal Article
The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family
Pereira, J. N. dos S.; Tadjerpisheh, S.; Abu Abed, M.; Saadatmand, A. R.; Weksler, B.; Romero, I. A. & Couraud, P.-O. et al. (2014)
The AAPS Journal, 16(6) pp. 1247-1258. DOI: https://doi.org/10.1208/s12248-014-9649-9
Details DOI WoS
-
2014 | Journal Article
Genetic Polymorphisms in 11 beta-Hydroxysteroid Dehydrogenase Type 1 Correlate With the Postdexamethasone Cortisol Levels and Bone Mineral Density in Patients Evaluated for Osteoporosis
Siggelkow, H.; Etmanski, M.; Bozkurt, S.; Gross, P.; Koepp, R.; Brockmoeller, J. & Tzvetkov, M. V. (2014)
The Journal of Clinical Endocrinology & Metabolism, 99(2) pp. E293-E302. DOI: https://doi.org/10.1210/jc.2013-1418
Details DOI PMID PMC WoS
-
2014 | Journal Article | Letter Note
Does the haplotype Met408-Del420, which was apparently predictive for imatinib efficacy, really exist and how strongly may it affect OCT1 activity?
Tzvetkov, M. V.; Seitz, T. ; Bokelmann, K.; Mueller, T.; Brockmoeller, J. & Koepsell, H. (2014)
Blood, 123(9) pp. 1427-1429. DOI: https://doi.org/10.1182/blood-2013-11-535864
Details DOI PMID PMC WoS
-
2014 | Journal Article
PharmGKB summary: tramadol pathway
Gong, L. I.; Stamer, U. M.; Tzvetkov, M. V.; Altman, R. B. & Klein, T. E. (2014)
Pharmacogenetics and Genomics, 24(7) pp. 374-380. DOI: https://doi.org/10.1097/FPC.0000000000000057
Details DOI PMID PMC WoS
-
2013 | Conference Abstract
Functional and molecular genetic analyses of 9 newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes
Emmert, S.; Schaefer, A.; Gratchev, A.; Seebode, C.; Hofmann, L.; Schubert, S. & Laspe, P. et al. (2013)
JDDG Journal der Deutschen Dermatologischen Gesellschaft, 11(9)
Hoboken: Wiley-blackwell.
Details WoS
-
2013 | Conference Abstract
Functional molecular-genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations
Schaefer, A.; Hofmann, L.; Gratchev, A.; Laspe, P.; Schubert, S.; Schuerer, A. & Ohlenbusch, A. et al. (2013)
Experimental Dermatology, 22(3) pp. E21-E22. 40th Annual Meeting of the Association-of-Dermatological-Research, Dessau, GERMANY.
Hoboken: Wiley-blackwell.
Details WoS
-
2013 | Journal Article |
Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration
Tzvetkov, M. V.; Pereira, J. N. dos S.; Meineke, I.; Saadatmand, A. R.; Stingl, J. C. & Brockmoeller, J. (2013)
Biochemical Pharmacology, 86(5) pp. 666-678. DOI: https://doi.org/10.1016/j.bcp.2013.06.019
Details DOI PMID PMC WoS